Total Funding
38
54
Total FundingSeed raised
Growth Score 38 in past quarter
2 pts
Heat Score 54 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
142505
Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life.
- David Enfrun: Co-Founder & Chief Executive Officer
- Gilles Bos: Co-Founder & Chairman
About the Company
Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life through the compensation of visual accommodation decay. Addressing presbyopia in the field of ophthalmology, with an anti-aging mindset in order to treat the gradual loss of visual accommodation.
Kejako SA is a privately held company
founded in March 2015 and based in Geneva, Switzerland. The company address presbyopia in the field of ophthalmology with a breakthrough approach combining simulation and minimally invasive treatment: all-in-one solution.
